These Analysts Revise Their Forecasts On RH After Q2 Results

RH RH reported upbeat second-quarter earnings.

RH reported quarterly earnings of $3.93 per share, which beat the analyst consensus estimate of $2.56, a 51.36% decrease over earnings of $8.08 per share from last year. The company reported quarterly sales of $800.48 million, which beat the analyst consensus estimate of $784.90 million, a 19.28% decrease over sales of $991.62 million in the same period last year.

RH also sees third-quarter revenue between $740 million and $760 million, versus the $772.87 million estimate, and fourth-quarter revenue between $760 million and $800 million versus the $774.71 million estimate.

RH shares fell 12% to trade at $324.44 on Friday.

These analysts made changes to their price targets on RH following earnings announcement.

• Wells Fargo raised the price target on RH from $300 to $375. Wells Fargo analyst Zachary Fadem maintained an Overweight rating.
• UBS cut the price target on RH from $350 to $340. UBS analyst Michael Lasser maintained a Neutral rating.
• Citigroup lowered the price target on RH from $460 to $440. Citigroup analyst Steven Zaccone maintained a Buy rating.

Check This Out: Top 5 Health Care Stocks That May Explode In Q3